Hodgkin Lymphoma Recurrent

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2015-02-23
Clinical Trial Update: SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial of SGN-30 (brentuximab vedotin) in combination with chemotherapy for relapsed or refractory Hodgkin lymphoma reported results.